Praluent is the name of the new drug approved by US regulators for people with certain genetic risk factors for heart disease.
The new drug is not in oral form, it is an injectable drug, made by Sanofi and Regeneron, and it is the first of its kind to gain approval on the US market, and offers an alternative to popular pill-based statins.
However, the US Food and Drug Administration approved it only for adults with an inherited condition that predisposes them to high cholesterol and raises the risk of heart attack and stroke.
The drug is not currently available in Nigeria, but there's hope it will get to Nigeria soon.
Good news for those who says "injection better pass tablet"
Stay healthy!
No comments:
Post a Comment